Experience: Testimonials
Listen to the “voice of our customers” to help you decide
if The Next Phase is the right consulting firm with the right solutions
at the right time for you.
From Richard Klein, CEO Mycosol, Inc. (formerly, CEO of Angiosonics,
Inc.):
The Next Phase's quick assessment of our technology and competitive
situation was 'spot on.' Vicky is a consummate professional and has proved,
on several occasions, that she understands the dynamics of product and
market development. Her observations, comments, and guidance helped better
focus our strategic planning process. Thereafter, I've recommended TNP
to numerous business colleagues, several of whom have subsequently used
her services. The feedback to me has been consistent: "Excellent.
Thank you for the referral."
From Russell D. Van Zandt, President of ELA
Medical (formerly CEO of CardioLogic Systems, Inc.)
Our work with The Next Phase was more than satisfying. We found the
work to be extremely thorough and comprehensive as well as timely. I would
strongly recommend The Next Phase in any aspect of medical technology
assessment, planning, development and execution.
From Jan Price, Vice President of Marketing International Technidyne
Corporation
The results from the Next Phase are always completely thorough. TNP's
team and Vicky Hunsicker Sanko, its founder, have excellent follow-up
and communication skills. In particular, Vicky goes the extra mile to
make sure the client is informed and has appropriate insight every step
of the way.
From Aaron Feldman, CEO Rafael
Medical Technologies, Inc.
The [Next Phase's] market research project was useful in that it provided
us and our investors with a more objective measure of the demand for our
product and also was useful in helping us better define our device and
end user segments.
From Paul Molloy, Senior Vice President of Sales and Marketing, Endologix,
Inc. (formerly Executive VP Radiance Medical Systems):
I was just browsing another section of the 'restenosis' report - this
time on drug delivery. Let me say again what a tremendous job your team
has done on this! It is a huge amount of work, extremely thorough and
well laid out. The purchase has been a very worthwhile investment, from
my perspective. I will be briefing our board of directors next week on
strategic investment opportunities for our company in this area and the
data you have summarized has been invaluable in preparing for this.
From Cheryl Liberatore, Director of Corporate Development REVA
Medical.
The Next Phase's Restenosis Report was very comprehensive and the information
was categorized in a user-friendly manner. It provided a wonderful foundation
for fully understanding the interventional cardiology market, particularly
the developing area of drug-eluting stents.
In addition, The Next Phase was able to quickly provide a follow-up,
customized market research report on specific areas where we wanted more
detailed information. The cost/value ratio was very positive.
We would highly recommend TNP to any of its prospective clients.
We invite you to contact us if you are
Ready for growth... Ready
for The Next Phase
Last modified
November 3, 2003
SERVICES |
EXPERIENCE |
PUBLICATIONS |
ABOUT US |
OUTSIDE U.S.
Our Partners |
Search |
Contact |
Privacy |
Home
The Next Phase Consultancy, Inc.
Phone: 425.869.8724 / Fax: 425.869.9397
e-mail:
Trademark information:
The Next Phase and The Next Phase "Moons" logo are registered trademarks, and The Next Phase SMArt Chart, CPI, PTMA, SMA, TNP and TNP SMArt Chart are trademarks of The Next Phase Consultancy, Inc. Send mail to , with questions or comments about this web site.
Copyright © 2007 The Next Phase Consultancy, Inc. All rights reserved.
|